8-K: Regen Biopharma Appoints Bush and Associates CPA LLC as New Independent Auditor

Regen Biopharma has replaced its independent auditor with Bush and Associates CPA LLC, effective May 28, 2024.

Summary

• Regen Biopharma's Board of Directors, acting as the Audit Committee, approved the engagement of Bush and Associates CPA LLC as their new independent auditor on May 28, 2024.
• Bush and Associates CPA LLC was officially engaged as the company's new independent registered public accounting firm on the same date.

Sentiment

Score: 5

Explanation: The document reports a routine change of auditor, which is neither positive nor negative in itself. It is a neutral event from an investment perspective.

Industry Context

Changes in auditors are a normal part of corporate governance and can occur for various reasons, including the desire for a fresh perspective or cost considerations. This change is not unusual in the context of the broader industry.

Comparison to Industry Standards

• The appointment of a new auditor is a common practice among publicly traded companies.
• Companies often change auditors to ensure independence and compliance with regulatory requirements.
• The selection of Bush and Associates CPA LLC is consistent with the practice of engaging a registered public accounting firm.

Stakeholder Impact

• The change of auditor is unlikely to have a significant impact on stakeholders.

Key Dates

Keywords

independent auditor, accounting firm, audit committee, Regen Biopharma, Bush and Associates CPA LLC